On this page you will find information about the University of Kentucky Research response to COVID-19 and the University of Kentucky Resumption of Research Phased Plan. During Phase 1, when only essential research is allowed on-campus, a Waiver is required. During Phases 2-4, a Plan is required for all research and creative activities to conduct their work safely. Details for all these Phases are found in the Plan link below, along with COVID-19-related guidance and links for relevant Research Support Units.
UK Resources for Researchers
CURE Alliance Teams
We established three COVID-19 Unified Research Experts (CURE) Alliance teams to facilitate and coordinate COVID-19 research within a given area at UK; to align COVID-19 research in given area to funding opportunities; and to serve as a liaison both within and external to UK in area COVID-19 related research. For more on our Health, Materials/Methods and Social Sciences teams visit the CURE Alliance site.
OSPA: Agency Specific Guidance for Grants & Contracts
Please visit the Office of Sponsored Projects Administration's COVID-19 Updates for Agency Specific Guidance for Sponsored Projects
ORI & CCTS: Clinical Research & Human Research Updates
Office of Research Integrity:
- COVID-19 Alerts for Clinical Research
- COVID-19 Alerts for Human Research (IRB related updates)
- COVID-19 Human Research FAQS
Center for Clinical and Translational Science (CCTS): Guidance for Research Participants During COVID-19
OTC: Commercialization Activities Related to COVID-19
The Office of Technology Commercialization (OTC) has a new site to support our researchers, connect potential research partners, move COVID-19 relevant technologies into the marketplace quickly, and help facilitate and showcase activities by UK startups, innovators and regional companies in support of front-line health care workers. This site includes:
- COVID-19 specific license
- COVID-19 UK technology portfolio
- Webforms to collect info from:
- outside partners who want to collaborate with UK researchers on COVID-19 related work
- UK researchers with activity related to COVID-19
- FDA compliance and regulations links
Visit site: https://www.research.uky.edu/otc/covid19
March 20, 2020: Universities urge U.S. leaders to boost science budgets by 15%, ease rules to cope with pandemic
*Update, 20 March, 12:45 p.m.: Last night, the White House Office of Management and Budget issued a new directive that gives universities the flexibility they are seeking to deal with disruptions to research caused by the coronavirus pandemic. “It’s almost exactly what we asked for,” says Wendy Streitz of the Council on Governmental Relations, a nonprofit representing hundreds of research institutions.
Now, it’s up to federal agencies to spell out exactly how those changes will affect tens of thousands of grantees. Look for that information on agency FAQs. And keep checking for updates.
The U.S. research community is urgently asking the White House and Congress to take steps aimed at keeping academic research—as well as museums, botanic gardens, and zoos—afloat during the coronavirus pandemic.
Four organizations representing the nation’s major research institutions and medical schools today wrote to congressional leaders, urging them to increase research spending at federal science agencies by some 15%, or $13 billion, in order to prevent students and researchers in all scientific disciplines from going broke, to help closed laboratories restart once the pandemic eases, and to cover other unanticipated costs to the academic research enterprise. Read more.
March 17, 2020: White House Unveils Digital Database for Coronavirus Research
Link to database. You will need to log in to request a demo.
- Database has 29,000 scholarly articles on coronavirus pandemic
- U.S. technology official urges tech giants to mine studies
The White House Office of Science and Technology Policy on Monday unveiled a new database with thousands of scientific articles about the coronavirus in an effort to help public health experts combat the worsening pandemic.
U.S. Chief Technology Officer Michael Krastios told reporters that the new database is a “call to action” for tech companies to use artificial intelligence to mine the research to answer important questions about the virus.
The new database, which already has some 29,000 scholarly articles, is the latest effort by tech companies and the Office of Science and Technology Policy to coordinate a response to the health crisis.
Last week, Krastios led a call with Amazon.com Inc., Apple Inc., Microsoft Corp. and International Business Machines Corp. to discuss how tech platforms can combat misinformation about the virus and products on the internet.
Eric Horvitz, Microsoft’s chief scientific officer, said the database will help scientists stay on top of “thousands of articles.” Other groups working on the effort include the Allen Institute for AI, a research organization started by Microsoft co-founder Paul Allen and the Chan Zuckerberg Initiative, a philanthropy group created by Facebook Inc. Chief Executive Officer Mark Zuckerberg and his wife, Priscilla Chan.
How can I contact UK Research?
If you have questions related to COVID research operations, please contact the Office of the Vice President for Research.